The impact of allograft nephrectomy on percent panel reactive antibody and clinical outcome.
Khakhar
A K
AK
Department of Surgery/Urology, London Health Sciences Centre, London, Ontario, Canada.
Shahinian
V B
VB
House
A A
AA
Muirhead
N
N
Hollomby
D J
DJ
Leckie
S H
SH
McAlister
V C
VC
Chin
J L
JL
Jevnikar
A M
AM
Luke
P P W
PP
D000208:Acute Disease; D000328:Adult; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000601:surgery*; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology* / Q000473:pathology; D009392:Nephrectomy; D011183:Postoperative Complications / Q000145:classification*; D012086:Reoperation / Q000706:statistics & numerical data; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology* / Q000473:pathology; D017211:Treatment Failure; D016896:Treatment Outcome
D007518:Isoantibodies